A randomized controlled trial of two methods of oxytocin infusion administration in prevention of blood loss at caesarean section

A randomized controlled trial of early versus late administration of oxytocin infusion in prevention of blood loss at caesarean section

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201909775190644

Enrollment

210

Registered

2019-09-18

Start date

2019-02-04

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

Group One

Group Two

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: pregnant women with a single fetus at term >37 weeks of gestational age, with American Society of Anesthesiology (ASA) physical status I or II

Exclusion criteria

Exclusion criteria: Women at high risk for uterine atony such as anemia (Hb <8 g/dL), multiple gestation, polyhydramnios placenta previa, fetal macrosomia two or more previous CS preeclampsia, current or previous history of heart disease, liver, renal disorders or known coagulopathy

Design outcomes

Primary

Measure	Time frame
Blood loss during caesarean section	—

Secondary

Measure	Time frame
Post-operative blood loss, Difference in pre- and post-operative packed cell volume/ haemoglobin concentration need for additional uterotonics need for blood transfusion need for additional surgical procedures	—

Countries

Nigeria

Contacts

Public ContactOluwadare Ipinnimo

Senior Registrar

stildrdare@yahoo.com+2348033748593

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026